TV Résistance

Connexion

Parcourir les chaines | fr | en | es | it | de | ru | ar | zh | tr | he | hi | Censuré | Non Censuré | MERDIA | OLIGARCHIE | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |pertinence | vues | plus | date |titre | nb_com | Uploads : UUW_3ykt68GF9dmOyus-OeXw |

VaccineSafetyConf

2 Vidéos sur 12
(1 068 abonnés 123 480 vues 0 Commentaires )
Crée le 2011-10-06

| |

Page 1 | Suivant

2 Vidéos en Anglais

2011-11-14 | HORS-SUJET |

vus : 5 039 votes : 33-2 com : 4 (en)
VaccineSafetyConf | (Y) | (Ajax)
Vaccine Safety Conference Session 18: Dr. Romain Gherardi | (Y) | Romain Gherardi |
Nanosized particles injected into muscle slowly disseminate within phagocytes Dr. Romain K. Gherardi is a French specialist of neuromuscular diseases. He graduated in clinical Neurology and Pathology, and has been a Professor since 1990. He is working at the Henri Mondor hospital, the second largest hospital of Assistance Publique- Hôpitaux de Paris, located in Créteil and depending of Paris-Est University. He heads the department of Histology that includes both Neuropathologic and Clinical activities in the setting of a Neuromuscular disease reference center. He also heads an experimental research team entitled 'Cellular interactions in the Neuromuscular system" (INSERM U955-E10) at the Institut Mondor de Recherche Biomédicale (IMRB). From 1983 to 2010, Gherardi has published 290 articles indexed in PubMed, and monitored 14 PhD and 10 MSc students on the topic of biology, pathology and clinics of the nervous and muscular system. He previously studied several immuno-inflammatory and toxic neuromuscular disorders (almitrine neuropathy, zidovudine myopathy, statin myopathy, etc). He is currently working on innate immune reactions to myoinjury, biodistribution of nanoparticles, and pathophysiology of 'macrophagic myofasciitis" a neurologic disease linked to the long term persistence of Alum adjuvant in monocyte/macrophage lineage cells. Gherardi is reviewer for Science, N Engl J Med, Lancet, Ann Neurol, Arthritis Rheum, Stem Cells, Stem Cell Dev, Neuromuscular Disord, Muscle Nerve, etc. On the topic of macrophagic myofasciitis, he was an invited speaker by the Centers for Disease Control, WHO Geneva, French government agencies, the French Parliament committee on Gulf War syndrome, and a variety of national and international scientific and medical societies.
Vaccines | Vaccine Safety | Science | NVIC | aluminum | adjuvants | autoimmunity | Autoimmune | autism | vaccine research | Neuromuscular

2011-11-04 | HORS-SUJET |

vus : 58 733 votes : 481-9 com : 49 (en)
VaccineSafetyConf | (Y) | (Ajax)
Vaccine Safety Conference Session 16 Dr. Christopher Exley | (Y) | Christopher Exley |
Dr. Christopher Exley- The Systemic Toxicity of Aluminium Adjuvants. Dr. Christopher Exley is the Reader in Bioinorganic Chemistry at The Birchall Centre, Keele University in Staffordshire and Honorary Professor at the UHI Millennium Institute. Exley is a biologist (University of Stirling) with a PhD in the ecotoxicology of aluminium (University of Stirling). His research career (1984-present) has focused upon an intriguing paradox; 'how the third most abundant element of the Earth's crust (aluminium) is non-essential and largely inimical to life'. Investigating this mystery has required research in myriad fields from the basic inorganic chemistry of the reaction of aluminium and silicon to the potentially complex biological availability of aluminium in humans. Exley is also fascinated by the element silicon in relation to living things which, as the second most abundant element of the Earth's crust, is also almost devoid of biological function. One possible function of silicon is to keep aluminium out of biology (biota) and this area of study forms a large part of Exley's research.
Vaccines | Vaccine Safety | Science | NVIC | aluminum | adjuvants | autoimmunity | Autoimmune | autism | vaccine research

Page 1 | Suivant